HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myungshin Kim Selected Research

Remission Induction

2/2020Evaluation of posaconazole plasma concentrations achieved with the delayed-release tablets in Korean high-risk patients with haematologic malignancy.
1/2020Prognostic Role of Postinduction Minimal Residual Disease and Myeloid Sarcoma Type Extramedullary Involvement in Pediatric RUNX1-RUNX1T1 (+) Acute Myeloid Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Myungshin Kim Research Topics

Disease

19Neoplasms (Cancer)
11/2021 - 01/2003
13Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2022 - 01/2004
10Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 10/2003
9BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2024 - 01/2002
9Multiple Myeloma
06/2023 - 12/2007
7Infections
01/2023 - 04/2005
7Leukemia
01/2021 - 01/2004
6Disease Progression
04/2017 - 04/2005
5Sepsis (Septicemia)
01/2021 - 03/2015
5Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2020 - 02/2008
4Inflammation (Inflammations)
10/2023 - 01/2006
4Hepatocellular Carcinoma (Hepatoma)
03/2021 - 01/2013
4Chromosome Aberrations (Chromosome Abnormalities)
12/2014 - 01/2005
3Paraproteinemias (Monoclonal Gammopathy)
09/2022 - 05/2014
3Residual Neoplasm
01/2022 - 02/2008
3Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2006
3Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 03/2014
2Blast Crisis (Blast Phase)
11/2022 - 03/2014
2Philadelphia Chromosome
01/2021 - 11/2012
2Optic Atrophy
10/2020 - 10/2014
2Mucositis
09/2020 - 10/2015
2Invasive Fungal Infections
02/2020 - 10/2015
2Diarrhea
10/2015 - 01/2006
2Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
05/2015 - 01/2008
2Trisomy (Trisomies)
12/2014 - 06/2006
2Osteochondrodysplasias (Spondyloepiphyseal Dysplasia)
11/2014 - 05/2012
2Diamond-Blackfan Anemia (Anemia, Diamond Blackfan)
08/2014 - 03/2014
2Thrombocytopenia (Thrombopenia)
07/2009 - 01/2007
2Peripheral Nervous System Diseases (PNS Diseases)
07/2009 - 12/2007
2Carcinoma (Carcinomatosis)
01/2004 - 01/2003
1Cardiomyopathies (Cardiomyopathy)
04/2024
1Genetic Predisposition to Disease (Genetic Predisposition)
04/2024
1Breast Neoplasms (Breast Cancer)
04/2024
1Vaginitis
10/2023
1Ossification of Posterior Longitudinal Ligament
02/2023
1Primary Myelofibrosis (Myelosclerosis)
01/2023
1Dent disease 1
01/2023
1Cytomegalovirus Infections (Inclusion Disease)
10/2022
1Multiple Organ Failure (MODS)
10/2022
1Immunoglobulin G4-Related Disease
09/2022
1Heart Failure
07/2022
1Myocardial Infarction
07/2022
1Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
04/2022

Drug/Important Bio-Agent (IBA)

10CytokinesIBA
10/2023 - 01/2006
9DNA (Deoxyribonucleic Acid)IBA
10/2021 - 04/2005
6Biomarkers (Surrogate Marker)IBA
03/2021 - 06/2008
5Proteins (Proteins, Gene)FDA Link
09/2022 - 01/2005
4Tyrosine Kinase InhibitorsIBA
03/2024 - 01/2022
4Immunoglobulins (Immunoglobulin)IBA
01/2022 - 01/2013
4Nonsense Codon (Nonsense Mutation)IBA
10/2021 - 07/2017
4Bortezomib (Velcade)FDA Link
01/2015 - 01/2007
4Imatinib Mesylate (Gleevec)FDA Link
03/2014 - 05/2006
3Mitochondrial DNA (mtDNA)IBA
10/2020 - 10/2014
3Interleukin-6 (Interleukin 6)IBA
01/2019 - 03/2015
3Interleukin-5 (Interleukin 5)IBA
09/2018 - 01/2006
3Interleukin-10 (Interleukin 10)IBA
09/2018 - 01/2006
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
07/2018 - 01/2005
2Blood Proteins (Serum Proteins)IBA
09/2022 - 09/2022
2Transforming Growth Factor-beta Type II ReceptorIBA
01/2022 - 03/2013
2Circulating Tumor DNAIBA
11/2021 - 08/2021
2Carcinoembryonic AntigenIBA
05/2020 - 01/2003
2posaconazoleFDA Link
02/2020 - 10/2015
2Hemoglobins (Hemoglobin)IBA
03/2019 - 07/2013
2GlobinsIBA
03/2019 - 01/2019
2Interleukin-9 (Interleukin 9)IBA
01/2019 - 09/2018
2Interleukin-22 (IL-22)IBA
01/2019 - 09/2018
2Interleukin-4 (Interleukin 4)IBA
09/2018 - 01/2006
2EnzymesIBA
03/2017 - 10/2015
2Phosphotransferases (Kinase)IBA
01/2016 - 05/2006
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2016 - 07/2009
2Colony-Stimulating Factors (Colony Stimulating Factor)IBA
05/2015 - 10/2003
2N 30IBA
03/2015 - 01/2006
2DNA ProbesIBA
12/2014 - 06/2006
2AntigensIBA
05/2014 - 02/2008
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2013 - 10/2006
2SolutionsIBA
11/2012 - 01/2002
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2010 - 01/2008
2Paclitaxel (Taxol)FDA LinkGeneric
02/2007 - 01/2006
2Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2005 - 01/2004
1AnthracyclinesIBA
04/2024
1daratumumabIBA
06/2023
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2023
1Ferritins (Ferritin)IBA
02/2023
1ChloridesIBA
01/2023
1fms-Like Tyrosine Kinase 3IBA
12/2022
1Antiviral Agents (Antivirals)IBA
10/2022
1FoscarnetFDA LinkGeneric
10/2022
1Ganciclovir (Cytovene)FDA LinkGeneric
10/2022
1Cidofovir (Vistide)FDA Link
10/2022
1Leflunomide (Arava)FDA LinkGeneric
10/2022
1Immunoglobulin G (IgG)IBA
09/2022

Therapy/Procedure

14Therapeutics
04/2024 - 01/2004
10Drug Therapy (Chemotherapy)
04/2024 - 01/2004
6Cell Transplantation
01/2023 - 02/2008
6Stem Cell Transplantation
11/2020 - 01/2002
5Hematopoietic Stem Cell Transplantation
01/2022 - 03/2015
3Transplantation
01/2021 - 02/2008
2Aftercare (After-Treatment)
04/2024 - 03/2014
2Remission Induction
02/2020 - 01/2020
1Pessaries
10/2023